𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A leukocyte adherence inhibition (LAI) assay of anti-tumor immunity in rats using selective radioimmunological assessment of adherence of T lymphocytes and monocytes

✍ Scribed by Dr. Toshio Morizane; Hans Olov Sjögren


Publisher
John Wiley and Sons
Year
1983
Tongue
French
Weight
936 KB
Volume
31
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A new, highly sensitive micro‐glass‐tube leukocyte adherence inhibition (LAI) assay has been developed to detect anti‐tumor sensitization in a rat colon carcinoma system. This technique requires fewer cells and smaller amounts of antigen preparations than the previous glass tube method. The microscopic enumeration of adherent cells is replaced by a cellular radioimmunoassay (CRIA) which utilizes antibodies binding to mononuclear cells (MNC) and ~125~I‐labelled protein A. Antigen preparations were shown to be adsorbed to glass. Precoating of glass vials with fetal calf serum or antigen preparations was shown to cause a major increase in nonspecific LAI. The new LAI technique is designed to minimize such nonspecific LAI. By applying an anti‐T‐cell monoclonal antibody (McAb), an anti‐lg antiserum and an anti‐monocyte (MC) antiserum it became possible to assess selectively the change of adherence of T cells, B cells and monocytes. The specificity of the assay was demonstrated with anti‐T‐cell and anti‐MC reagents in criss‐cross experiments using two defined antigens and different tissue extracts as test antigens. The LAI response of peripheral blood MNC was examined after the subcutaneous isografting of 1 × 10^7^ X‐irradiated DMH‐W49 colon carcinoma cells. Six days after sensitization all the rats showed an LAI response detectable with anti‐T‐cell and anti‐MC reagents, which gave considerably higher LAI indices than anti‐MNC antiserum. After the subcutaneous isografting of 1 × 10^5^ viable DMH‐W49 cells, 12 of 24 rats (50%) showed an LAI response detectable with the anti‐MNC antiserum during a 3‐week follow‐up period. On the other hand, an LAI response was detected in all the 14 tumor‐inoculated rats tested when the adherence of T lymphocytes and monocytes was assessed selectively.


📜 SIMILAR VOLUMES


Detection of different states of immunit
✍ Dr. Toshio Morizane; Hans Olov Sjögren 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 French ⚖ 400 KB

## Abstract Peripheral blood mononuclear cells (MNC) of rats, which had received a subcutaneous inoculation of either viable or X‐irradiated syngeneic DMH‐W49 colon carcinoma cells, were investigated sequentially for sensitization against tumor‐associated antigens by a new micro‐glass‐tube leukocyt

Demonstration of tumor-associated immuni
✍ Ingegerd Hellström; Karl Erik Hellström; Geraldine Shantz 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 French ⚖ 655 KB

## Abstract A modification of the leukocyte adherence inhibition (LAI) assay of Halliday was used to search for immune reactions against tumor‐associated antigens of mouse tumors as well as against embryonic antigens in such neoplasms. Soluble antigen extracts were prepared from transplanted (BALB/

Tube leukocyte (monocyte) adherence inhi
✍ N. Grosser; D. M. P. Thomson 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 French ⚖ 769 KB

## Abstract Leukocytes from patients with limited cancer display LAI reactivity whereas leukocytes from patients with metastatic cancer frequently demonstrate no reactivity in the tube LAI assay. The leukocytes (monocytes) of reactive patients react with tumour antigen through specific cytophilic a

Prospective evaluation of the leukocyte
✍ D. Fritze; G. Fedra; M. Kaufmann 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 French ⚖ 447 KB

## Abstract The antigen‐induced leukocyte adherence inhibition (LAI) test is an assay of cellular immune reactivity which was expected to offer a promising adjunct to currently available diagnostic and monitoring procedures in cancer patients. We have applied this assay to (1) 83 inpatients clinica